Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study.
Saved in:
| Title: | Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. |
|---|---|
| Authors: | Lynce F; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057-1400, USA., Barac A; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057-1400, USA.; MedStar Heart & Vascular Institute, Washington, DC, USA., Geng X; Department of Biostatistics, Bioinformatics & Biomathematics, Georgetown University Medical Center, Washington, DC, USA., Dang C; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yu AF; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Smith KL; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Gallagher C; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC, USA., Pohlmann PR; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057-1400, USA., Nunes R; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.; The Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Herbolsheimer P; AstraZeneca, Gaithersburg, MD, USA., Warren R; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057-1400, USA., Srichai MB; MedStar Heart & Vascular Institute, Washington, DC, USA.; Department of Cardiology, MedStar Georgetown University Hospital, Washington, DC, USA., Hofmeyer M; MedStar Heart & Vascular Institute, Washington, DC, USA., Cunningham A; MedStar Health Research Institute, Hyattsville, MD, USA., Timothee P; MedStar Health Research Institute, Hyattsville, MD, USA., Asch FM; MedStar Heart & Vascular Institute, Washington, DC, USA.; MedStar Health Research Institute, Hyattsville, MD, USA., Shajahan-Haq A; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057-1400, USA., Tan MT; Department of Biostatistics, Bioinformatics & Biomathematics, Georgetown University Medical Center, Washington, DC, USA., Isaacs C; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057-1400, USA., Swain SM; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057-1400, USA. sandra.swain@georgetown.edu. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2019 Jun; Vol. 175 (3), pp. 595-603. Date of Electronic Publication: 2019 Mar 09. |
| Publication Type: | Clinical Trial; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-019-05191-2 |
